71 related articles for article (PubMed ID: 1984489)
1. Tumor-associated neurological dysfunction prevented by lazaroids in rats.
King WA; Black KL; Ikezaki K; Conklin S; Becker DP
J Neurosurg; 1991 Jan; 74(1):112-5. PubMed ID: 1984489
[TBL] [Abstract][Full Text] [Related]
2. Novel 21-aminosteroids prevent tumour associated neurological dysfunction.
King WA; Black KL; Ikezaki K; Conklin S; Becker DP
Acta Neurochir Suppl (Wien); 1990; 51():160-2. PubMed ID: 2089884
[TBL] [Abstract][Full Text] [Related]
3. U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.
Hall ED; Braughler JM; Yonkers PA; Smith SL; Linseman KL; Means ED; Scherch HM; Von Voigtlander PF; Lahti RA; Jacobsen EJ
J Pharmacol Exp Ther; 1991 Aug; 258(2):688-94. PubMed ID: 1865365
[TBL] [Abstract][Full Text] [Related]
4. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia.
Park CK; Hall ED
Brain Res; 1994 May; 645(1-2):157-63. PubMed ID: 8062078
[TBL] [Abstract][Full Text] [Related]
5. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot.
Kanamaru K; Weir BK; Simpson I; Witbeck T; Grace M
J Neurosurg; 1991 Mar; 74(3):454-9. PubMed ID: 1993911
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of mechanistically different antioxidants in the rat hemorrhagic shock model.
Fleckenstein AE; Smith SL; Linseman KL; Beuving LJ; Hall ED
Circ Shock; 1991 Dec; 35(4):223-30. PubMed ID: 1777958
[TBL] [Abstract][Full Text] [Related]
7. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.
Hall ED; Pazara KE; Braughler JM
Stroke; 1991 Mar; 22(3):361-6. PubMed ID: 2003306
[TBL] [Abstract][Full Text] [Related]
8. Protective actions of 21-aminosteroids and MK-801 on hypoxia-induced electrophysiological changes in rat hippocampal slices.
Domenici MR; Longo R; de Carolis AS; Frank C; Sagratella S
Eur J Pharmacol; 1993 Mar; 233(2-3):291-3. PubMed ID: 8467875
[TBL] [Abstract][Full Text] [Related]
9. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F).
Althaus JS; Andrus PK; Williams CM; VonVoigtlander PF; Cazers AR; Hall ED
Mol Chem Neuropathol; 1993 Oct; 20(2):147-62. PubMed ID: 8297419
[TBL] [Abstract][Full Text] [Related]
10. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673.
Behrmann DL; Bresnahan JC; Beattie MS
Exp Neurol; 1994 Mar; 126(1):61-75. PubMed ID: 8157127
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tirilazad mesylate (U-74006F) and methylprednisolone sodium succinate treatments in experimental allergic encephalomyelitis in the guinea pig.
Karlik SJ; Stavraky RT; Hall ED
Mult Scler; 1996 Feb; 1(4):228-35. PubMed ID: 9345440
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and excretion of the 21-aminosteroid antioxidant U-74006F in rat and perfused rat liver.
Cox JW; Larson PG; Wynalda MA; Sood VK; Verburg MT; Pullen RN
Drug Metab Dispos; 1989; 17(4):373-9. PubMed ID: 2571475
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats.
Zuccarello M; Anderson DK
Stroke; 1989 Mar; 20(3):367-71. PubMed ID: 2493691
[TBL] [Abstract][Full Text] [Related]
14. 21-aminosteroid and 2-(aminomethyl)chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers.
Shi F; Cavitt J; Audus KL
Free Radic Biol Med; 1995 Sep; 19(3):349-57. PubMed ID: 7557549
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant lazaroids enhance differentiation of C2 skeletal muscle cells.
Vernier A; Metzinger L; Warter JM; Poindron P; Passaquin AC
Neurosci Lett; 1995 Feb; 186(2-3):177-80. PubMed ID: 7777191
[TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury.
Anderson DK; Braughler JM; Hall ED; Waters TR; McCall JM; Means ED
J Neurosurg; 1988 Oct; 69(4):562-7. PubMed ID: 3418389
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of tirilazad mesylate (U-74006F), mannitol, and their combination on experimental ischemia.
Oktem IS; Menkü A; Akdemir H; Kontaş O; Kurtsoy A; Koç RK
Res Exp Med (Berl); 2000 Feb; 199(4):231-42. PubMed ID: 10743681
[TBL] [Abstract][Full Text] [Related]
18. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage.
Zuccarello M; Marsch JT; Schmitt G; Woodward J; Anderson DK
J Neurosurg; 1989 Jul; 71(1):98-104. PubMed ID: 2661744
[TBL] [Abstract][Full Text] [Related]
19. Testing lazaroids U-74389G and U-83836E for therapeutic value in experimental allergic encephalomyelitis in the Lewis rat.
Milford CM; Lynch SG; Cross RS; LeVine SM
Res Commun Mol Pathol Pharmacol; 1995 Mar; 87(3):353-8. PubMed ID: 7620828
[TBL] [Abstract][Full Text] [Related]
20. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion.
Andrus PK; Taylor BM; Sun FF; Hall ED
Brain Res; 1994 Oct; 659(1-2):126-32. PubMed ID: 7820653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
